Suppression of AP-1 activity by cycloprodigiosin hydrochloride

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 9, 2007, Pages 1792-1795

  Kawauchi, Keiko ^a,b   Tobiume, Kei ^c   Kaneko, Shuhei ^b   Kaneshiro, Keiko ^b   Okamoto, Shiho ^b   Ueda, Emi ^b   Kamata, Hideaki ^b   Moriyama, Yoshinori ^d   Hirata, Hajime ^b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b HYOGO UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

Activator protein 1; Mitogen activated protein kinase; Nuclear factor (NF) B; Prodigiosin

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPRODIGIOSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PRODIGIOSIN; PROTEIN P300; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; GENE; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; MEKK1 GENE; NONHUMAN; ONCOGENE RAS; PROTEIN FAMILY; PROTEIN SYNTHESIS INHIBITION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

BIOTRANSFORMATION; BLOTTING, WESTERN; CELL LINE, TUMOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENES, REPORTER; HELA CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUCIFERASES; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PLASMIDS; PYRROLES; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548639938     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.1792     Document Type: Article

References (14)

1. Shaulian E., Karin M., Nat. Cell. Biol., 4, 131-136 (2002).
2. Shaulian E., Karin M., Oncogene, 20, 2390-2400 (2001).
3. Chang L., Karin M., Nature (London), 410, 37-40 (2001).
4. Kawauchi K., Shibutani K., Yagisawa H., Kamata H., Nakatsuji S., Anzai H., Yokoyama Y., Ikegami Y., Noriyama Y., Hirata H., Biochem. Biophys. Res. Commun., 237, 543-547 (1997).
5. Nakayasu T., Kawauchi K., Hirata H., Shimmen T., Plant Cell Physiol., 41, 857-863 (2000).
6. Yamamoto C., Takemoto H., Kuno K., Yamamoto D., Tsubura A., Kamata K., Hirata H., Yamamoto A., Kano H., Seki T., Inoue K., Hepatology, 30, 894-902 (1999).
7. Kamata K., Okamoto S., Oka S., Kamata H., Yagisawa H., Hirata H., FEBS Lett., 507, 74-80 (2001).
8. Xie K., Cytokine Growth Factor Rev., 12, 375-391 (2001).
9. Mukhopadhyay A., Bueso-Ramos C., Chatterjee D., Pantazis P., Aggarwal B. B., Oncogene, 20, 7597-7609 (2001).
10. Mori N., Fujii M., Iwai K, Ikeda S., Yamasaki Y., Hata T., Yamada Y., Tanaka Y., Tomonaga M., Yamamoto N., Blood, 95, 3915-3921 (2000).
11. Rayet B., Gelinas C., Oncogene, 18, 6938-6947 (1999).
12. Bhat-Nakshatri P., Newton T. R., Goulet R., Jr., Nakshatri H., Proc. Natl. Acad. Sci. U.S.A., 95, 6971-6976 (1998).
13. Williamson N. R., Fineran P. C., Leeper F. J., Salmond G. P., Nat. Rev. Microbiol., 4, 887-899 (2006).
14. Mortellaro A., Songia S., Gnocchi P., Ferrari M., Fornasiero C., D'Alessio R., Isetta A., Colotta F., Golay J., J. Immunol., 162, 7102-7109 (1999).